SCHEMBL20744262

SCHEMBL20744262

O=C(O)N1CC[C@@H]2CCNC[C@H]21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 4/20 0.36
GABRA5 P31644 3/20 0.36
GABRB2 P47870 3/20 0.36
SLC6A11 P48066 3/20 0.36
SLC6A13 Q9NSD5 3/20 0.36
SLC6A12 P48065 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRA4 P48169 2/20 0.36
GABRR1 P24046 1/20 0.36
CHRNB2 P17787 3/20 0.34
CHRNB4 P30926 3/20 0.34
CHRNA3 P32297 3/20 0.34
CHRNA4 P43681 3/20 0.34
TSHR P16473 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA3 P34903 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1470518 1.00 SLC6A1 (0.36) SLC6A1GABRA5GABRB2SLC6A11SLC6A13
SCHEMBL27198371 1.00 SLC6A1 (0.36) SLC6A1GABRA5GABRB2SLC6A11SLC6A13
SCHEMBL20136819 1.00 SLC6A1 (0.36) SLC6A1GABRA5GABRB2SLC6A11SLC6A13
SCHEMBL27145812 0.91 GABRA5 (0.36) SLC6A1GABRA5GABRB2SLC6A11SLC6A13
SCHEMBL334462 0.85 SLC6A1 (0.36) SLC6A1GABRA5GABRB2SLC6A11SLC6A13
SCHEMBL20744258 0.85 SLC6A1 (0.36) SLC6A1GABRA5GABRB2SLC6A11SLC6A13
SCHEMBL18692612 0.85 SLC6A1 (0.36) SLC6A1GABRA5GABRB2SLC6A11SLC6A13
SCHEMBL3579211 0.85 PARP1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1033901 0.85 PARP1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3582591 0.85 PARP1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668882-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2020-06-24 EP disclosed
WO-2019034890-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2019-02-21 WO disclosed